BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8617876)

  • 1. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis.
    Sankar S; Mahooti-Brooks N; Bensen L; McCarthy TL; Centrella M; Madri JA
    J Clin Invest; 1996 Mar; 97(6):1436-46. PubMed ID: 8617876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro.
    Papapetropoulos A; Desai KM; Rudic RD; Mayer B; Zhang R; Ruiz-Torres MP; García-Cardeña G; Madri JA; Sessa WC
    Am J Pathol; 1997 May; 150(5):1835-44. PubMed ID: 9137106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro.
    Teti A; De Giorgi A; Spinella MT; Migliaccio S; Canipari R; Onetti Muda A; Faraggiana T
    Int J Cancer; 1997 Sep; 72(6):1013-20. PubMed ID: 9378535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultured tubule cells from TGF-beta1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose.
    Chen S; Hoffman BB; Lee JS; Kasama Y; Jim B; Kopp JB; Ziyadeh FN
    Kidney Int; 2004 Apr; 65(4):1191-204. PubMed ID: 15086458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
    Yamamoto H; Ueno H; Ooshima A; Takeshita A
    J Biol Chem; 1996 Jul; 271(27):16253-9. PubMed ID: 8663151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine stimulation of endometrial angiogenesis.
    Sandberg T; Casslén B; Gustavsson B; Benraad TJ
    Biol Reprod; 1998 Oct; 59(4):759-67. PubMed ID: 9746723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
    Albo D; Berger DH; Vogel J; Tuszynski GP
    J Gastrointest Surg; 1999; 3(4):411-7. PubMed ID: 10482694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro.
    Merwin JR; Newman W; Beall LD; Tucker A; Madri J
    Am J Pathol; 1991 Jan; 138(1):37-51. PubMed ID: 1846264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M; Miyazaki H; Kojima S
    J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
    Odekon LE; Blasi F; Rifkin DB
    J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of actin mRNAs in cultured vascular cells by matrix components and TGF-beta 1.
    Kocher O; Madri JA
    In Vitro Cell Dev Biol; 1989 May; 25(5):424-34. PubMed ID: 2659578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of urokinase-type plasminogen activator by transforming growth factor beta1 in acetaldehyde-activated hepatic stellate cells.
    Pérez-Liz G; Flores-Hernández J; Arias-Montaño JA; Reyes-Esparza JA; Rodríguez-Fragoso L
    Pharmacology; 2005 Jan; 73(1):23-30. PubMed ID: 15452360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.
    McCaffrey TA; Consigli S; Du B; Falcone DJ; Sanborn TA; Spokojny AM; Bush HL
    J Clin Invest; 1995 Dec; 96(6):2667-75. PubMed ID: 8675633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
    Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
    J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes.
    Kocic J; Bugarski D; Santibanez JF
    Eur J Cancer; 2012 Jul; 48(10):1550-7. PubMed ID: 21798735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis.
    Merwin JR; Anderson JM; Kocher O; Van Itallie CM; Madri JA
    J Cell Physiol; 1990 Jan; 142(1):117-28. PubMed ID: 1688859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-beta and subsequently suppresses TGF-beta signalings.
    Yagyu T; Kobayashi H; Wakahara K; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    FEBS Lett; 2004 Oct; 576(3):408-16. PubMed ID: 15498571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of protease and extracellular matrix protein expression by transforming growth factor-beta 1 in non-small cell lung cancer cells and normal human bronchial epithelial cells.
    Jakowlew SB; Mariano JM; You L; Mathias A
    Biochim Biophys Acta; 1997 Aug; 1353(2):157-70. PubMed ID: 9294010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-induced fibronectin and collagen type III expression in renal fibroblasts can occur independent of TGF-beta1.
    Lam S; Verhagen NA; Strutz F; van der Pijl JW; Daha MR; van Kooten C
    Kidney Int; 2003 Mar; 63(3):878-88. PubMed ID: 12631068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-beta 1.
    Iruela-Arispe ML; Sage EH
    J Cell Biochem; 1993 Aug; 52(4):414-30. PubMed ID: 7693728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.